+33 1 76 70 47 90
/
creativ@creativ-ceutical.com
Home
Who We Are
About Us
Strategic Management Board
What we do
Value & Market Access
Payer Landscape
Pricing Research
Early Dialog
PRMA Strategy
Evidence Generation
Decision Sciences & Outcomes Research
Modeling
HTA submission
Data Analytics
Evidence Synthesis
Patient-Centered Research
Real World Evidence
Exclusive Customized Consulting
Biotech Strategic Consulting
Corporate Strategic Consulting
Expertise
Senior Management
Partnerships
Japan
Publications
News & Events
Careers
Contact
Home
Who We Are
About Us
Strategic Management Board
What we do
Value & Market Access
Payer Landscape
Pricing Research
Early Dialog
PRMA Strategy
Evidence Generation
Decision Sciences & Outcomes Research
Modeling
HTA submission
Data Analytics
Evidence Synthesis
Patient-Centered Research
Real World Evidence
Exclusive Customized Consulting
Biotech Strategic Consulting
Corporate Strategic Consulting
Expertise
Senior Management
Partnerships
Japan
Publications
News & Events
Careers
Contact
Meta-Analysis in Open Bugs: How To Assess the Convergence of Mcmc Chain?
Home
Publications
Meta-Analysis in Open Bugs: How To Assess the Convergence of Mcmc Chain?
Back Home
Meta-Analysis in Open Bugs: How To Assess the Convergence of Mcmc Chain?
2014 Value Health
Laliman, V. | Roiz, J. |
Volume: 17, Issue: 7, Pages: A577,
https://www.doi.org/10.1016/j.jval.2014.08.1944
The website uses cookies.
Learn More
Ok
